VitaStem/BIO
VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.
Score | |
|---|---|
24h Vol | $172.17 |
Liquidity | $68K |
Holders | 1.2K |
Audits | |
Age | 7 months |
FDV | $603.3K |
Market Cap | $192.6K |
| Addresses | |
|---|---|
| Pool | |
| VitaStem |  |
| BIO | |
VitaStem to BIO Converter
Score | |
|---|---|
24h Vol | $172.17 |
Liquidity | $68K |
Holders | 1.2K |
Audits | |
Age | 7 months |
FDV | $603.3K |
Market Cap | $192.6K |
About VitaStem (VitaStem)
VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.
Other Pools Trading VitaStem (VitaStem)
VitaStem/BIO Price Stats
The current price of VitaStem (VitaStem/BIO) on Uniswap V3 (Base) is $0.06033, the price is up -8.48% in the last 24 hours. Its 24-hour trading volume is reported to be at $172.17 with a total of 18 transactions. VitaStem/BIO contract address is 0x7ae935b63e99382fb19dc90c6ec30a2e6017ee23, with a Fully Diluted Valuation (FDV) of $603.33K and a liquidity pool of $67,997.12.
